SRPT - Sarepta Therapeutics, Inc.
16.09
0.220 1.367%
Share volume: 2,068,645
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$15.87
0.22
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-01-2024 | 08-07-2024 | 11-06-2024 | 02-28-2025 | 05-06-2025 | 08-06-2025 | 11-06-2025 | |
| Cash flow financing | 22.140 M | 39.918 M | 13.757 M | 48.991 M | 12.471 M | -23.817 M | -117.790 M | |
| Other financing cash flows | 0.000 | 39.918 M | 13.757 M | 49.059 M | 12.471 M | 1.196 M | 606.000 K | |
| Cash flow | -242.076 M | -43.668 M | -185.767 M | 905.155 M | -862.143 M | 269.731 M | 100.025 M | |
| Net income | 36.119 M | 6.460 M | 33.611 M | 159.049 M | -447.508 M | 196.892 M | -179.947 M | |
| Depreciation | 12.696 M | 8.719 M | 9.806 M | 10.455 M | 9.978 M | 10.840 M | 18.450 M | |
| Changes in inventories | 373.530 M | 0.000 | 0.000 | 0.000 | 177.359 M | 0.000 | 0.000 | |
| Changes in receivables | 412.107 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 218.796 M | -98.528 M | -128.825 M | 764.118 M | -291.177 M | 32.211 M | 232.400 M | |
| Net Borrowings | -439.982 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -42.444 M | 29.167 M | 37.263 M | 38.082 M | 43.651 M | 31.796 M | 22.934 M | |
| Cash Change | 1.391 B | -43.668 M | -185.767 M | 905.155 M | -862.143 M | 269.731 M | 100.025 M |